bromanil
Description
Bromanil, also known as tetrabromo-1,4-benzoquinone, is a yellow crystalline solid with a molecular formula of C6Br4O2. It is synthesized through the bromination of 1,4-benzoquinone. Bromanil is a strong oxidizing agent and is used in organic synthesis as an electron acceptor in reactions like Diels-Alder reactions. Due to its high electron affinity, it is also studied for its potential in organic electronics and as a component in organic solar cells. Its properties and reactions are of interest to researchers in the fields of organic chemistry, materials science, and electrochemistry.'
bromanil: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 68101 |
| SCHEMBL ID | 638801 |
| MeSH ID | M0487387 |
Synonyms (43)
| Synonym |
|---|
| 488-48-2 |
| nsc-36927 |
| bromanil |
| tetrabromo-1,4-benzoquinone |
| p-bromanil |
| tetrabromo-p-benzoquinone |
| 2,4-dione, 2,3,5,6-tetrabromo- |
| p-benzoquinone,3,5,6-tetrabromo- |
| nsc36927 |
| 2,5,6-tetrabromo-1,4-benzoquinone |
| tetrabromoquinone |
| 2,5,6-tetrabromo-p-benzoquinone |
| bromanyl |
| tetrabromobenzoquinone |
| nsc 36927 |
| p-quinone, tetrabromo- |
| 2,3,5,6-tetrabromo-1,4-benzoquinone |
| p-benzoquinone, 2,3,5,6-tetrabromo- |
| p-bromoanil |
| p-benzoquinone, tetrabromo- |
| tetrabromo-p-quinone |
| 2,5-cyclohexadiene-1,4-dione, 2,3,5,6-tetrabromo- |
| einecs 207-679-4 |
| 2,3,5,6-tetrabromo-p-benzoquinone |
| 2,3,5,6-tetrabromocyclohexa-2,5-diene-1,4-dione |
| T0617 |
| AKOS001030624 |
| FT-0623203 |
| SCHEMBL638801 |
| tetrabromobenzo-1,4-quinone |
| AKOS025243337 |
| tetrabromocyclohexa-2,5-diene-1,4-dione |
| 2,3,5,6-tetrabromobenzo-1,4-quinone # |
| DTXSID20197608 |
| q312 tetrabromo-1,4-benzoquinone |
| mfcd00013785 |
| 2,3,5,6-tetrabromo-(1,4)benzoquinone |
| BBL104054 |
| STL557868 |
| AS-18102 |
| A871873 |
| D92370 |
| CS-W009681 |
Research Excerpts
Dosage Studied
| Excerpt | Relevance | Reference |
|---|---|---|
| "Three simple and sensitive spectrophotometric methods were developed and validated for determination of the hydrochloride salts of fluoxetine, sertraline, and paroxetine in their pharmaceutical dosage forms." | ( Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms. Darwish, IA, ) | 0.13 |
| " The methods developed were applied successfully to the determination of the subject drugs in their pharmaceutical dosage forms with good precision and accuracy compared to official and reported methods as revealed by t- and F-tests." | ( Study of fluorescence characteristics of the charge-transfer reaction of quinolone agents with bromanil. Chen, XF; Li, WY; Xuan, CS, 2009) | 0.57 |
Bioassays (2)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 24.62
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (24.62) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||